Akay, O. M. I. Et Al. 2014. BCL2, BCL6, IGH, TP53, and MYC protein expression and gene rearrangements as prognostic markers in diffuse large B-cell lymphoma: a study of 44 Turkish patients. CANCER GENETICS , vol.207, no.3 , 87-93.

Akay, O. M. I., Aras, B. D., Isiksoy, S., Toprak, Ç., Mutlu, F. S., Artan, S., ... Oner, U.(2014). BCL2, BCL6, IGH, TP53, and MYC protein expression and gene rearrangements as prognostic markers in diffuse large B-cell lymphoma: a study of 44 Turkish patients. CANCER GENETICS , vol.207, no.3, 87-93.

Akay, Olga Et Al. "BCL2, BCL6, IGH, TP53, and MYC protein expression and gene rearrangements as prognostic markers in diffuse large B-cell lymphoma: a study of 44 Turkish patients," CANCER GENETICS , vol.207, no.3, 87-93, 2014

Akay, Olga M. Et Al. "BCL2, BCL6, IGH, TP53, and MYC protein expression and gene rearrangements as prognostic markers in diffuse large B-cell lymphoma: a study of 44 Turkish patients." CANCER GENETICS , vol.207, no.3, pp.87-93, 2014

Akay, O. M. I. Et Al. (2014) . "BCL2, BCL6, IGH, TP53, and MYC protein expression and gene rearrangements as prognostic markers in diffuse large B-cell lymphoma: a study of 44 Turkish patients." CANCER GENETICS , vol.207, no.3, pp.87-93.

@article{article, author={Olga Me Item Akay Et Al. }, title={BCL2, BCL6, IGH, TP53, and MYC protein expression and gene rearrangements as prognostic markers in diffuse large B-cell lymphoma: a study of 44 Turkish patients}, journal={CANCER GENETICS}, year=2014, pages={87-93} }